Answers are grounded in this paper and cite their sources.
Evaluating outcomes among the millions of HIV-infected patients starting antiretroviral therapy (ART) in settings with limited resources is key to understanding the effect of current treatment programs and guiding future strategies. Accurately assessing survival outcomes has been precluded by substantial numbers of patients not returning for care. One year after starting ART 15% to 30% of patients are lost to follow-up. Only by determining the outcomes of those lost can true survival and program impact be understood. We present a sampling-based strategy to address this. (excerpt)
No takes yet. Share an insight, caveat, or question.
Elvin Geng (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: